M&A in biotech and pharma is expected to surge in late 2024 as regulatory uncertainties ease. Discover trends, key players, and areas of high interest.

An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted the ire of a pharmaceutical trade organisation that calls the campaign "nothing short ...

Envision Pharma Group said the deal would also enrich its global reach in medical affairs, while also providing 90TEN’s London-based team with significant geographical expansion opportunities.

Spanish renewables developer X-Elio has signed a virtual power purchase agreement (vPPA) with a cohort of pharmaceutical companies for a 369MW solar project in Spain. The deal was signed with the ...

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

And it sounds like lessons from the past are fresh in their memories. Mayne Pharma Group boss Scott Richards says the outlook is positive across the specialty pharmaceutical group with a more ...

Mitsubishi Tanabe Pharma, also known as Tanabe Pharma, is the pharmaceutical division of Mitsubishi Chemical Group. Under deal terms announced Friday, this pharma unit, which traces its origins to ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...